Latest Breaking News On - Laras sullivan - Page 4 : comparemela.com

Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update

Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesLaras sullivanCompany annual report on formSociety for the immunotherapy of cancerApexigen incPyxis oncology incExchange commissionPyxis oncologyChief executive officerAnnual meetingInternational associationLung cancerPrivate securities litigation reform actAnnual reportSecurities act

Pyxis Oncology to Present at BTIG Virtual Biotechnology Conference

Pyxis Oncology to Present at BTIG Virtual Biotechnology Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLaras sullivanPyxis oncology incCompany quarterly report on formChief executive officerBiotechnology conferencePyxis oncologyPrivate securities litigation reform actQuarterly report

CancerVAX CEO Ryan Davies Discusses Biotech Entrepreneurship with Pyxis Oncology CEO Dr Lara Sullivan

CancerVAX CEO Ryan Davies Discusses Biotech Entrepreneurship with Pyxis Oncology CEO Dr Lara Sullivan
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLaras sullivanKlara sullivanRyan daviesCancervax incWorldwide research developmentCornell universityUniversity of pennsylvania school medicineUniversity of pennsylvaniaWharton schoolDavies discusses biotech entrepreneurshipPyxis oncologyPyxis oncology presidentChief executive officerFounding presidentSpringworks therapeutics

Pyxis Oncology (PYXS) to Acquire Apexigen (APGN) for $0 64/sh

Pyxis Oncology (PYXS) to Acquire Apexigen (APGN) for $0 64/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWilson sonsini goodrich rosatiJan pinkasXiaodong yangJaym feingoldPamela connealyLaras sullivanNovarti beovuContactjennifer davis ruffviceApexigen contactwilliam dukechief financial officerapexigen incLadenburg thalmann coAmerican society of clinical oncologyApexigen incFlexible antibody conjugation technologyLegal advisors sidley austinPyxis oncology inc

Pyxis Oncology : to Acquire Apexigen - Form 8-K

Pyxis Oncology to Acquire Apexigen Pyxis Oncology positioned at forefront of Antibody-Drug Conjugate development Commercially and clinically validated APXiMAB. | May 24, 2023

United statesLaras sullivanWilliam dukeXiaodong yangWilson sonsini goodrich rosatiJaym feingoldNovarti beovuPamela connealyJan pinkasApexigen incPyxis oncology incAmerican society of clinical oncologySidley austinLadenburg thalmann coFlexible antibody conjugation technologyExchange commission